FDA approval

launch button
Pharma

IntraBio hits the ground running with new rare disease launch

With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease.
Fraiser Kansteiner Sep 30, 2024 3:25pm
COPD

FDA signs off on Regeneron and Sanofi's Dupixent for COPD

Sep 27, 2024 9:40am
drug launch launch takeoff

IntraBio snags FDA nod in rare disease just days after Zevra

Sep 25, 2024 9:50am
flu influenza flu vaccine cold sick

AZ's FluMist wins FDA nod as first self-administered flu vaccine

Sep 20, 2024 3:24pm
stop light green

Zevra snags FDA approval for new lysosomal storage disorder med

Sep 20, 2024 1:54pm
Traffic light go start restart green light

FDA approves Galderma's prurigo nodularis treatment Nemluvio

Aug 13, 2024 10:37am